BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38758229)

  • 1. Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency.
    Shi X; Cao X; Huang M; Zhang P; Yang G; Ren A; Dai X; Chen R; Yang Z; Cai Z; Chen Y; Zhao X; Huang P; Du Z
    J Clin Immunol; 2024 May; 44(5):117. PubMed ID: 38758229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.
    Kuehn HS; Chang J; Yamashita M; Niemela JE; Zou C; Okuyama K; Harada J; Stoddard JL; Nunes-Santos CJ; Boast B; Baxter RM; Hsieh EWY; Garofalo M; Fleisher TA; Morio T; Taniuchi I; Dutmer CM; Rosenzweig SD
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34694366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIOLOS-Associated Inborn Errors of Immunity.
    Yamashita M; Morio T
    J Clin Immunol; 2024 May; 44(6):128. PubMed ID: 38773004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIOLOS Variants Causing Immunodeficiency in Human and Mice.
    Yamashita M; Morio T
    Front Immunol; 2022; 13():866582. PubMed ID: 35444653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired tissue homing by the Ikzf3
    Chang J; Yamashita M; Padhi AK; Zhang KYJ; Taniuchi I
    Front Immunol; 2023; 14():1239779. PubMed ID: 37662955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal SCID Newborn Screening and Spontaneous Recovery Associated with a Novel Haploinsufficiency IKZF1 Mutation.
    Kuehn HS; Gloude NJ; Dimmock D; Tokita M; Wright M; Rosenzweig SD; Collins C
    J Clin Immunol; 2021 Aug; 41(6):1241-1249. PubMed ID: 33855675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS.
    Yamashita M; Kuehn HS; Okuyama K; Okada S; Inoue Y; Mitsuiki N; Imai K; Takagi M; Kanegane H; Takeuchi M; Shimojo N; Tsumura M; Padhi AK; Zhang KYJ; Boisson B; Casanova JL; Ohara O; Rosenzweig SD; Taniuchi I; Morio T
    Nat Immunol; 2021 Jul; 22(7):893-903. PubMed ID: 34155405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T Cells from Patients with Rheumatoid Arthritis Are Characterized by Reduced Expression of Ikaros Zinc Finger Transcription Factors.
    Dittrich-Salamon M; Meyer A; Yan S; Steinbach-Knödgen E; Kotschenreuther K; Stahl D; Tho Pesch C; Schiller J; Byrtus F; Jochimsen D; Golumba-Nagy V; Kofler DM
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial effects of splice variants modulate function of Aiolos.
    Caballero R; Setien F; Lopez-Serra L; Boix-Chornet M; Fraga MF; Ropero S; Megias D; Alaminos M; Sanchez-Tapia EM; Montoya MC; Esteller M; Gonzalez-Sarmiento R; Ballestar E
    J Cell Sci; 2007 Aug; 120(Pt 15):2619-30. PubMed ID: 17646674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated STAT3 and Ikaros Zinc Finger Transcription Factor Activities Regulate Bcl-6 Expression in CD4
    Read KA; Powell MD; Baker CE; Sreekumar BK; Ringel-Scaia VM; Bachus H; Martin RE; Cooley ID; Allen IC; Ballesteros-Tato A; Oestreich KJ
    J Immunol; 2017 Oct; 199(7):2377-2387. PubMed ID: 28848064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
    Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
    Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus.
    Schafer PH; Ye Y; Wu L; Kosek J; Ringheim G; Yang Z; Liu L; Thomas M; Palmisano M; Chopra R
    Ann Rheum Dis; 2018 Oct; 77(10):1516-1523. PubMed ID: 29945920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation.
    Morgan B; Sun L; Avitahl N; Andrikopoulos K; Ikeda T; Gonzales E; Wu P; Neben S; Georgopoulos K
    EMBO J; 1997 Apr; 16(8):2004-13. PubMed ID: 9155026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes.
    Yomogida K; Trsan T; Sudan R; Rodrigues PF; Ulezko Antonova A; Ingle H; Luccia BD; Collins PL; Cella M; Gilfillan S; Baldridge MT; Oltz EM; Colonna M
    Nat Immunol; 2024 Jan; 25(1):77-87. PubMed ID: 38049581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inborn errors of IKAROS and AIOLOS.
    Yamashita M; Morio T
    Curr Opin Immunol; 2021 Oct; 72():239-248. PubMed ID: 34265590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene.
    Goldman FD; Gurel Z; Al-Zubeidi D; Fried AJ; Icardi M; Song C; Dovat S
    Pediatr Blood Cancer; 2012 Apr; 58(4):591-7. PubMed ID: 21548011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N160 of Aiolos Determines its DNA-Binding Activity.
    Wang H; Xu Z; Du W; Lin Z; Liu Z
    Anat Rec (Hoboken); 2019 Nov; 302(11):2014-2019. PubMed ID: 31251838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains.
    Kuehn HS; Sakovich IS; Niemela JE; Gil Silva AA; Stoddard JL; Polyakova EA; Esteve Sole A; Aleshkevich SN; Uglova TA; Belevtsev MV; Vertelko VR; Shman TV; Kupchinskaya AN; Walter JE; Fleisher TA; Notarangelo LD; Peng XP; Delmonte OM; Sharapova SO; Rosenzweig SD
    J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38015619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells.
    Hung JJ; Kao YS; Huang CH; Hsu WH
    Sci Rep; 2019 Feb; 9(1):2991. PubMed ID: 30816208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
    Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
    Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.